Elevation of anti-cytokeratin 19 antibody in sera of the patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with collagen vascular disorders

Lung

Volumn 177, Issue 5, 1999, Pages 311-319

  Fujita, Jiro ^a   Dobashi, N ^a   Ohtsuki, Y ^b   Yamadori, I ^c   Yoshinouchi, T ^d   Kamei, T ^e   Tokuda, M ^a   Hojo, S ^a   Okada, H ^a   Takahara, J ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d Department of Respiratory Medicine   (Japan)

^e KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Antibody; Cytokeratin 19; Idiopathic pulmonary fibrosis; Pulmonary fibrosis associated with collagen vascular disorder

Indexed keywords

CYTOKERATIN 19;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOBLOTTING; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; VASCULAR DISEASE;

EID: 0032863068     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007649     Document Type: Article

References (21)

1. 1. Citron M, Diehl TS, Capell A, Haass C, Teplow DB, Selkoe DJ (1996) Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF. Neuron 17:171-179
2. 2. Cherniack RM (1990) Bronchoalveolar lavage constituents in healthy individuals, interstitial pulmonary fibrosis and selected comparison groups. Am Rev Respir Dis 141(Suppl):S169-193
3. 3. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA (1984) Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310:154-166
4. 4. Dobashi N, Fujita J, Ohtsuki Y, Yamadori I, Yoshinouchi T, Kamei T, Tokuda M, Hojo S, Takahara J (1998) Detection of anti-cytokeratin 8 antibody in sera of the patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders. Thorax 53:969-974
5. 5. Hirakata Y, Kobayashi J, Sugama Y, Kitamura S (1995) Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis. Eur Respir J 8:689-696
6. 6. Iyonaga K, Miyafuji M, Suga M, Saita N, Ando M (1997) Alterations in cytokeratin expression by the alveolar lining epithelial cells in lung tissue from patients with idiopathic pulmonary fibrosis. J Pathol 182:217-224
7. 7. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680
8. 8. Marks N, Berg MJ, Chi LM, Choi J, Durrie R, Swistok J, Makofske RC, Danho W, Sapirstein VS (1994) Hydrolysis of amyloid precursor protein-derived peptides by cysteine proteinases and extracts of rat brain clathrin-coated vesicles. Peptides 15:175-182
9. 9. Marks N, Berg MJ, Sapirstein VS, Durrie R, Swistok J, Makofske RC, Danho W (1995) Brain cathepsin B but not metalloendopeptidases degrade rAPP751 with production of amyloidogenic fragments: comparison with synthetic peptides emulating beta-and gamma-secretase sites. Int J Pept Protein Res 46:306-313
10. 10. Nakamura H, Abe S, Shibata Y, Yuki H, Suzuki H, Saito H, Sata M, Kato S, Tomoike H (1997) Elevated levels of cytokeratin 19 in the bronchoalveolar lavage fluid in patients with chronic airway inflammatory disease: a specific marker for bronchial epithelial injury. Am J Respir Crit Care Med 155:1217-1221
11. 11. Peterson MW, Monick M, Hunninghake GW (1987) Prognostic role of eosinophils in pulmonary fibrosis. Chest 92:51-56
12. 12. Pujol JL, Grenier J, Daures JP, Daver A, Pujol H, Michel FB (1993) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 53:61-66
13. 13. Pujol JL, Grenier J, Parrat E, Lehmann M, Lafontaine T, Quanyin X, Michel FB (1996) Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS. Am J Respir Crit Care Med 154:725-733
14. 14. Reynolds HY, Fulmer JD, Kazamierowski JA, Roberts WC, Frank MM, Crystal RG (1977) Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 59:165-175
15. 15. Satoh H, Ishikawa H, Fujiwara M, Yamashita YT, Ohtsuka M, Ogata T, Hasegawa S, Kammma H (1997) Production of cytokeratin 19 fragment by human squamous lung cancer cell lines. Am J Respir Cell Mol Biol 16:597-604
16. 16. Selkoe DJ, Yamazaki T, Citron M, Podlisny MB, Koo EH, Teplow DB, Haass C (1996) The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. Ann NY Acad Sci 777:57-64
17. 17. Stigbrand T, Andres C, Bellanger L, Bishr Omary M, Bodenmuller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Levi M, Meier T, Nap M, Nustad K, Seguin P, Sjodin A, Sundstrom B, van Dalen A, Wiebelhaus E, Wiklund B, Arlestig L, Hilgers J (1998) Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop. Tumour Biol 19:132-152
18. 18. Suzuki A, Masuda T, Koito N, Suzuki T, Mita S, Matsuoka Y, Irimajiri S (1996) Studies of serum markers in patients with interstitial pneumonia/pulmonary fibrosis complicated with collagen diseases: clinical evaluation of CYFRA21-1. Ryumachi 36:837-843
19. 19. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci USA 76:4350-4354
20. 20. Wallace WAH, Roberts SN, Caldwell H, Thornton E, Greening AP, Lamb D, Howie SEM (1994) Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax 49: 218-224
21. 21. Wallace WAH, Schofiels JA, Lamb D, Howie SEM (1994) Localization of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 49:1139-1145